BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 31884304)

  • 21. Thyroid function parameters and TSH-receptor antibodies in healthy subjects and Graves' disease patients: a sequential study before, during and after pregnancy.
    González-Jiménez A; Fernández-Soto ML; Escobar-Jiménez F; Glinoer D; Navarrete L
    Thyroidology; 1993 Apr; 5(1):13-20. PubMed ID: 7508738
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Serum antibodies against the insulin-like growth factor-1 receptor (IGF-1R) in Graves' disease and Graves' orbitopathy.
    Marinò M; Rotondo Dottore G; Ionni I; Lanzolla G; Sabini E; Ricci D; Sframeli A; Mazzi B; Menconi F; Latrofa F; Vitti P; Marcocci C; Chiovato L
    J Endocrinol Invest; 2019 Apr; 42(4):471-480. PubMed ID: 30132285
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Change of circulating thyroid autoantibody titers in Graves' hyperthyroidism after antithyroid drugs therapy.
    Lin HD; Tai FT; Chen HD; Lee SP; Chang FY; Wang GG; Tang KT; Lee JK
    Zhonghua Yi Xue Za Zhi (Taipei); 1991 Feb; 47(2):86-90. PubMed ID: 1705860
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Thyroglobulin autoantibodies switch to immunoglobulin (Ig)G1 and IgG3 subclasses and preserve their restricted epitope pattern after 131I treatment for Graves' hyperthyroidism: the activity of autoimmune disease influences subclass distribution but not epitope pattern of autoantibodies.
    Latrofa F; Ricci D; Montanelli L; Piaggi P; Mazzi B; Bianchi F; Brozzi F; Santini P; Fiore E; Marinò M; Tonacchera M; Vitti P
    Clin Exp Immunol; 2014 Dec; 178(3):438-46. PubMed ID: 25134846
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evidence that TSH Receptor A-Subunit Multimers, Not Monomers, Drive Antibody Affinity Maturation in Graves' Disease.
    Rapoport B; Aliesky HA; Chen CR; McLachlan SM
    J Clin Endocrinol Metab; 2015 Jun; 100(6):E871-5. PubMed ID: 25856215
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [The relationship between serum thyroid autoantibodies, iodine intake, development and prognosis of Graves' disease].
    Chen W; Man N; Li YS; Shan ZY; Teng WP
    Zhonghua Nei Ke Za Zhi; 2006 Feb; 45(2):95-9. PubMed ID: 16624113
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Targeted expression of the human thyrotropin receptor A-subunit to the mouse thyroid: insight into overcoming the lack of response to A-subunit adenovirus immunization.
    Pichurin PN; Chen CR; Chazenbalk GD; Aliesky H; Pham N; Rapoport B; McLachlan SM
    J Immunol; 2006 Jan; 176(1):668-76. PubMed ID: 16365463
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The role of antithyroglobulin, antiperoxidase and anti-TSH receptor autoantibodies in amiodarone-induced thyrotoxicosis and amiodarone-induced hypothyroidism (A two-center study).
    Czarnywojtek A; Czarnocka B; Zgorzalewicz-Stachowiak M; Wolinski K; Fichna M; Plazinska MT; Stangierski A; Gut P; Miechowicz I; Komarowska H; Waligorska-Stachura J; Wasko R; Ruchala M
    Neuro Endocrinol Lett; 2015 Dec; 36(7):677-81. PubMed ID: 26859590
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Studies of retroorbital tissue xenografts from patients with Graves' ophthalmopathy in severe combined immunodeficient (SCID) mice: detection of thyroid-stimulating antibody.
    Mori S; Yoshikawa N; Tokoro T; Ikehara S; Inoue Y; Nishikawa M; Inada M
    Thyroid; 1996 Aug; 6(4):275-81. PubMed ID: 8875746
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of removing human Graves' thyroid xenografts after eight weeks in nude mice and rexenografting them into SCID mice.
    Yoshikawa N; Arreaza G; Morita T; Mukuta T; Resetkova E; Akasu F; Miller N; Jamieson C; Volpé R
    J Clin Endocrinol Metab; 1994 Feb; 78(2):367-74. PubMed ID: 8106624
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Characteristics of a monoclonal antibody to the thyrotropin receptor that acts as a powerful thyroid-stimulating autoantibody antagonist.
    Sanders J; Allen F; Jeffreys J; Bolton J; Richards T; Depraetere H; Nakatake N; Evans M; Kiddie A; Premawardhana LD; Chirgadze DY; Miguel RN; Blundell TL; Furmaniak J; Smith BR
    Thyroid; 2005 Jul; 15(7):672-82. PubMed ID: 16053383
    [TBL] [Abstract][Full Text] [Related]  

  • 32. 25 Hydroxyvitamin D Deficiency and Its Relationship to Autoimmune Thyroid Disease in the Elderly.
    Muscogiuri G; Mari D; Prolo S; Fatti LM; Cantone MC; Garagnani P; Arosio B; Di Somma C; Vitale G
    Int J Environ Res Public Health; 2016 Aug; 13(9):. PubMed ID: 27571093
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Human recombinant TSH preceding a therapeutic dose of radioiodine for multinodular goiters has no significant effect in the surge of TSH-receptor and TPO antibodies.
    Rubio IG; Perone BH; Silva MN; Knobel M; Medeiros-Neto G
    Thyroid; 2005 Feb; 15(2):134-9. PubMed ID: 15753672
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The development of transient hypothyroidism after iodine-131 treatment in hyperthyroid patients with Graves' disease: prevalence, mechanism and prognosis.
    Aizawa Y; Yoshida K; Kaise N; Fukazawa H; Kiso Y; Sayama N; Hori H; Abe K
    Clin Endocrinol (Oxf); 1997 Jan; 46(1):1-5. PubMed ID: 9059550
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Does thyroidectomy, radioactive iodine therapy, or antithyroid drug treatment alter reactivity of patients' T cells to epitopes of thyrotropin receptor in autoimmune thyroid diseases?
    Soliman M; Kaplan E; Abdel-Latif A; Scherberg N; DeGroot LJ
    J Clin Endocrinol Metab; 1995 Aug; 80(8):2312-21. PubMed ID: 7543112
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Studies of thyroid xenografts from Graves' disease in severe combined immunodeficient mice.
    Morita T; Yoshikawa N; Akasu F; Resetkova E; Arreaza G; Miller N; Jamieson C; Volpé R
    J Clin Endocrinol Metab; 1993 Jul; 77(1):255-61. PubMed ID: 8100830
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long-term effects of radioiodine on thyrotrophin receptor antibodies in Graves' disease.
    Aizawa Y; Yoshida K; Kaise N; Kaise K; Fukazawa H; Kiso Y; Mori K; Sayama N; Kikuchi K; Abe K
    Clin Endocrinol (Oxf); 1995 May; 42(5):517-22. PubMed ID: 7621571
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Thyrotropin receptor antibodies and Graves' disease, a side-effect of 131I treatment in patients with nontoxic goiter.
    Nygaard B; Knudsen JH; Hegedüs L; Scient AV; Hansen JE
    J Clin Endocrinol Metab; 1997 Sep; 82(9):2926-30. PubMed ID: 9284721
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Monoclonal antibodies to thyroid specific autoantigens.
    Akamizu T
    Autoimmunity; 2003; 36(6-7):361-6. PubMed ID: 14669943
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Anti-thyroid-stimulating hormone receptor antibodies determined by second-generation assay.
    Mankaï A; Toumi D; Chadli-Chaieb M; Ghedira-Besbes L; Saad F; Ouertani M; Sfar H; Jeddi M; Chaieb L; Ghedira I
    Clin Chem Lab Med; 2007; 45(1):26-9. PubMed ID: 17243910
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.